247 related articles for article (PubMed ID: 26972118)
1. Design, synthesis, and anti-breast cancer evaluation of new triarylethylene analogs bearing short alkyl- and polar amino-/amido-ethyl chains.
Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
Bioorg Med Chem Lett; 2016 Apr; 26(8):1963-9. PubMed ID: 26972118
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents.
Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
Eur J Med Chem; 2014 Oct; 86():211-8. PubMed ID: 25164760
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and bioevaluation of novel 6-(4-Hydroxypiperidino)naphthalen-2-ol-based potential Selective Estrogen Receptor Modulators for breast cancer.
Jha A; Yadav Y; Naidu AB; Rao VK; Kumar A; Parmar VS; MacDonald WJ; Too CK; Balzarini J; Barden CJ; Cameron TS
Eur J Med Chem; 2015 Mar; 92():103-14. PubMed ID: 25544690
[TBL] [Abstract][Full Text] [Related]
5. A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione.
Banti CN; Kyros L; Geromichalos GD; Kourkoumelis N; Kubicki M; Hadjikakou SK
Eur J Med Chem; 2014 Apr; 77():388-99. PubMed ID: 24681027
[TBL] [Abstract][Full Text] [Related]
6. Modeling, design and synthesis of new heteroaryl ethylenes active against the MCF-7 breast cancer cell-line.
Barresi V; Bonaccorso C; Consiglio G; Goracci L; Musso N; Musumarra G; Satriano C; Fortuna CG
Mol Biosyst; 2013 Oct; 9(10):2426-9. PubMed ID: 23900493
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of novel 1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a]indole-3-carboxamide analogs in MCF-7 and MDA-MB-468 breast cancer cell lines.
Kim YJ; Pyo JS; Jung YS; Kwak JH
Bioorg Med Chem Lett; 2017 Feb; 27(3):607-611. PubMed ID: 27993518
[TBL] [Abstract][Full Text] [Related]
8. Benzothiepin-derived molecular scaffolds for estrogen receptor modulators: synthesis and antagonistic effects in breast cancer cells.
Meegan MJ; Barrett I; Zimmermann J; Knox AJ; Zisterer DM; Lloyd DG
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):655-66. PubMed ID: 18035834
[TBL] [Abstract][Full Text] [Related]
9. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
Dandawate P; Ahmad A; Deshpande J; Swamy KV; Khan EM; Khetmalas M; Padhye S; Sarkar F
Bioorg Med Chem Lett; 2014 Jul; 24(13):2900-4. PubMed ID: 24835626
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Biological Investigation and Docking Study of Novel Chromen Derivatives as Anti-Cancer Agents.
Dube PN; Sakle NS; Dhawale SA; More SA; Mokale SN
Anticancer Agents Med Chem; 2019; 19(9):1150-1160. PubMed ID: 30848213
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J
Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antibreast cancer MCF-7 cells biological evaluation of heterocyclic analogs of resveratrol.
Du C; Dong MH; Ren YJ; Jin L; Xu C
J Asian Nat Prod Res; 2017 Sep; 19(9):890-902. PubMed ID: 27809606
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of biaryl aryl stilbenes/ethylenes as antimicrotubule agents.
Kumar AS; Reddy MA; Jain N; Kishor C; Murthy TR; Ramesh D; Supriya B; Addlagatta A; Kalivendi SV; Sreedhar B
Eur J Med Chem; 2013 Feb; 60():305-24. PubMed ID: 23313639
[TBL] [Abstract][Full Text] [Related]
14. N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells.
Prestegui-Martel B; Bermúdez-Lugo JA; Chávez-Blanco A; Dueñas-González A; García-Sánchez JR; Pérez-González OA; Padilla-Martínez II; Fragoso-Vázquez MJ; Mendieta-Wejebe JE; Correa-Basurto AM; Méndez-Luna D; Trujillo-Ferrara J; Correa-Basurto J
J Enzyme Inhib Med Chem; 2016; 31(sup3):140-149. PubMed ID: 27483122
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents.
Wu LT; Jiang Z; Shen JJ; Yi H; Zhan YC; Sha MQ; Wang Z; Xue ST; Li ZR
Eur J Med Chem; 2016 May; 114():328-36. PubMed ID: 27017265
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design and synthesis of conformationally constrained derivatives of methyl-piperidinopyrazole (MPP) with estrogen receptor (ER) antagonist activity.
Ragab MA; Elagawany M; Daabees H; Ahmed AF; Awad EM; Billon C; Elgendy B; Abouzid KAM; Kassab SE
Bioorg Chem; 2022 Feb; 119():105554. PubMed ID: 34923243
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs.
Gagic Z; Ivkovic B; Srdic-Rajic T; Vucicevic J; Nikolic K; Agbaba D
Eur J Pharm Sci; 2016 Jun; 88():59-69. PubMed ID: 27063330
[TBL] [Abstract][Full Text] [Related]
18. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells.
Martínez-Muñoz A; Prestegui-Martel B; Méndez-Luna D; Fragoso-Vázquez MJ; García-Sánchez JR; Bello M; Martínez-Archundia M; Chávez-Blanco A; Dueñas-González A; Mendoza-Lujambio I; Trujillo-Ferrara J; Correa-Basurto J
Anticancer Agents Med Chem; 2018; 18(11):1629-1638. PubMed ID: 29745344
[TBL] [Abstract][Full Text] [Related]
19. Microwave-assisted synthesis of sec/tert-butyl 2-arylbenzimidazoles and their unexpected antiproliferative activity towards ER negative breast cancer cells.
Abdul Rahim AS; Salhimi SM; Arumugam N; Pin LC; Yee NS; Muttiah NN; Keat WB; Abd Hamid S; Osman H; Mat Ib
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1255-60. PubMed ID: 23061895
[TBL] [Abstract][Full Text] [Related]
20. Bis-arylidene oxindoles as anti-breast-cancer agents acting via the estrogen receptor.
Pal A; Ganguly A; Ghosh A; Yousuf M; Rathore B; Banerjee R; Adhikari S
ChemMedChem; 2014 Apr; 9(4):727-32. PubMed ID: 24482362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]